Pipeline Moves: Phase I/II cystic fibrosis trial of Horizon asset cancelled, shot at further study drops
Novartis in uveal melanoma and Ascendis in hypoparathyroidism are also reviewed by Clinical Trials Arena.
By
Hormonal Disorders
Latest in
Hormonal Disorders
OPKO Health and Pfizer report positive Phase III data for somatrogon
OPKO Health and Pfizer have reported positive results from the Phase III clinical trial of somatrogon compared to Genotropin (somatropin)…